Kreatin: das am besten untersuchte Supplement
Wirksam, günstig, sicher – und längst nicht mehr nur für Kraftsportler.
Kreatinmonohydrat gehört zu den am gründlichsten untersuchten Nahrungsergänzungsmitteln überhaupt. Die Effekte auf Kraftleistung und Muskelmasse in Kombination mit Widerstandstraining sind in zahlreichen Studien konsistent.
Besonders relevant für ältere Erwachsene
Für ältere Erwachsene ist das besonders relevant: In Kombination mit Krafttraining fallen die Zuwächse an fettfreier Masse in mehreren Untersuchungen deutlich höher aus als unter Training allein.
Sicherheit und die Sorge um die Nieren
Die Sicherheitsdatenlage ist über Jahrzehnte solide. Die verbreitete Sorge um die Nierenfunktion bestätigt sich bei nierengesunden Personen in kontrollierten Studien nicht.
Kernaussagen
- Monohydrat ist die untersuchte Form – teurere Varianten bringen keinen Zusatznutzen.
- Wirkt nur in Kombination mit Trainingsreiz, nicht isoliert.
- Bei nierengesunden Personen über Jahrzehnte gute Sicherheitsdaten.
Vertiefen Wie viel mehr Kraft und Muskeln bringt Kreatin ab 60 wirklich?
Nächster Schritt Wie nehme ich Kreatin richtig ein – und wann lasse ich es besser?
Querverbindung Wie viel Protein brauche ich ab 50 für den Muskelerhalt? Belege (3)
Open-Access-Publikationen mit offener Lizenz, direkt verlinkt.
The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis
Abstract
<h4>Background</h4>This study aimed to evaluate the effects of creatine monohydrate supplementation on cognitive function in adults and explore its potential role in preventing and delaying cognitive impairment-related diseases.<h4>Methods</h4>Following the PRISMA 2020 guidelines, a systematic review with meta-analysis was conducted. Randomized controlled trials (RCTs) published between 1993 and 2024 were retrieved from PubMed, Scopus, and Web of Science databases. The study protocol was registered with PROSPERO (registration number: CRD42024533557). The impact of creatine supplementation on overall cognitive function, memory, executive function, attention, and information processing speed was assessed using standardized mean differences (SMD) and Hedge's g with 95% confidence intervals (CI).<h4>Results</h4>Sixteen RCTs involving 492 participants aged 20.8-76.4 years, including healthy individuals and patients with specific diseases, were selected. Creatine monohydrate was the form used in all included studies. Creatine supplementation showed significant positive effects on memory (SMD = 0.31, 95% CI: 0.18-0.44, Hedges's <i>g</i> = 0.3003, 95% CI: 0.1778-0.4228) and attention time (SMD = -0.31, 95% CI: -0.58 to -0.03, Hedges's <i>g</i> = -0.3004, 95% CI: -0.5719 to -0.0289), as well as significantly improving processing speed time (SMD = -0.51, 95% CI: -1.01 to -0.01, Hedges's <i>g</i> = -0.4916, 95% CI: -0.7852 to -0.1980). However, no significant improvements were found on
The effects of creatine supplementation on cognitive performance-a randomised controlled study
Abstract
<h4>Background</h4>Creatine is an organic compound that facilitates the recycling of energy-providing adenosine triphosphate (ATP) in muscle and brain tissue. It is a safe, well-studied supplement for strength training. Previous studies have shown that supplementation increases brain creatine levels, which might increase cognitive performance. The results of studies that have tested cognitive performance differ greatly, possibly due to different populations, supplementation regimens, and cognitive tasks. This is the largest study on the effect of creatine supplementation on cognitive performance to date.<h4>Methods</h4>Our trial was preregistered, cross-over, double-blind, placebo-controlled, and randomised, with daily supplementation of 5 g for 6 weeks each. We tested participants on Raven's Advanced Progressive Matrices (RAPM) and on the Backward Digit Span (BDS). In addition, we included eight exploratory cognitive tests. About half of our 123 participants were vegetarians and half were omnivores.<h4>Results</h4>Bayesian evidence supported a small beneficial effect of creatine. The creatine effect bordered significance for BDS (p = 0.064, η<sup>2</sup><sub>P</sub> = 0.029) but not RAPM (p = 0.327, η<sup>2</sup><sub>P</sub> = 0.008). There was no indication that creatine improved the performance of our exploratory cognitive tasks. Side effects were reported significantly more often for creatine than for placebo supplementation (p = 0.002, RR = 4.25). Vegetarians did not ben
Impact of Short-Term Creatine Supplementation on Muscular Performance among Breast Cancer Survivors
Abstract
Breast cancer (BC) is one of the most common cancers in the United States. Advances in detection and treatment have resulted in an increased survival rate, meaning an increasing population experiencing declines in muscle mass and strength. Creatine supplementation has consistently demonstrated improvements in strength and muscle performance in older adults, though these findings have not been extended to cancer populations.<h4>Purpose</h4>The purpose of this study was to investigate the effects of short-term creatine supplementation on muscular performance in BC survivors.<h4>Methods</h4>Using a double-blind, placebo-controlled, randomized design, 19 female BC survivors (mean ± SD age = 57.63 ± 10.77 years) were assigned to creatine (SUPP) (<i>n</i> = 9) or dextrose placebo (PLA) (<i>n</i> = 10) groups. The participants completed two familiarization sessions, then two test sessions, each separated by 7 days, where the participants supplemented with 5 g of SUPP or PLA 4 times/day between sessions. The testing sessions included sit-to-stand power, isometric/isokinetic peak torque, and upper/lower body strength via 10 repetition maximum (10RM) tests. The interaction between supplement (SUPP vs. PLA) and time (Pre vs. Post) was examined using a group × time ANOVA and effect sizes.<h4>Results</h4>No significant effects were observed for sit-to-stand power (<i>p</i> = 0.471; η<sub>p</sub><sup>2</sup> = 0.031), peak torque at 60°/second (<i>p</i> = 0.533; η<sub>p</sub><sup>2</sup> =
Quellen aus Europe PMC, ausschließlich CC0, CC BY oder CC BY-SA. Der redaktionelle Text ist eine eigene Formulierung, keine Übernahme aus den Originalarbeiten.
Medizinische Prüfung: Dr. med. Anna Reuter, Fachärztin für Innere Medizin, 01. April 2026.
Fehler gefunden oder eine Frage zum Beitrag? Wir prüfen jeden Hinweis gegen die Quellen.
Hinweis an den Leserservice